Kindstar Globalgene Technology, Inc. (HKG:9960)
Hong Kong · Delayed Price · Currency is HKD 1.090
+0.040 (3.81%)
At close: Mar 27, 2026
HKG:9960 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 933.57 | 927.57 | 967.26 | 1,387 | 930.67 | |
Revenue Growth (YoY) | 0.65% | -4.10% | -30.24% | 48.99% | 4.41% |
Cost of Revenue | 522.69 | 484.63 | 515.05 | 779.31 | 442.75 |
Gross Profit | 410.88 | 442.94 | 452.21 | 607.28 | 487.92 |
Selling, General & Admin | 426.54 | 382.44 | 413.41 | 440.97 | 351.75 |
Research & Development | 95.86 | 105.8 | 105.34 | 101.23 | 90.33 |
Other Operating Expenses | 63.81 | 118.74 | 17.45 | 37.9 | 17.72 |
Operating Expenses | 586.21 | 606.98 | 536.2 | 580.09 | 459.8 |
Operating Income | -175.33 | -164.04 | -83.99 | 27.19 | 28.13 |
Interest Expense | -14.91 | -11.09 | -8.03 | -2.52 | -1.81 |
Interest & Investment Income | - | 85.94 | 82.83 | 51.31 | 12.5 |
Earnings From Equity Investments | - | -0.43 | -0.57 | 2.45 | 1.1 |
Currency Exchange Gain (Loss) | - | -0.49 | -1.59 | 3.35 | -0.04 |
Other Non Operating Income (Expenses) | 149.85 | 34.05 | 36.12 | 17.7 | -1,478 |
EBT Excluding Unusual Items | -40.39 | -56.06 | 24.78 | 99.49 | -1,438 |
Impairment of Goodwill | - | -0.33 | -0.94 | - | - |
Gain (Loss) on Sale of Investments | - | - | 14.57 | -8.18 | 1.31 |
Gain (Loss) on Sale of Assets | - | -0.72 | -0.22 | -0.27 | 8.56 |
Asset Writedown | - | - | - | -13.31 | - |
Other Unusual Items | - | 0.92 | 5.14 | 5.59 | -25.48 |
Pretax Income | -40.39 | -56.19 | 43.32 | 83.32 | -1,454 |
Income Tax Expense | 14.76 | 4.49 | 6.88 | 5.83 | 0.25 |
Earnings From Continuing Operations | -55.15 | -60.68 | 36.45 | 77.48 | -1,454 |
Minority Interest in Earnings | -3.59 | 6.09 | 4.84 | -2.03 | -0.2 |
Net Income | -58.74 | -54.59 | 41.29 | 75.46 | -1,454 |
Net Income to Common | -58.74 | -54.59 | 41.29 | 75.46 | -1,454 |
Net Income Growth | - | - | -45.28% | - | - |
Shares Outstanding (Basic) | 992 | 946 | 958 | 795 | 496 |
Shares Outstanding (Diluted) | 992 | 946 | 971 | 818 | 496 |
Shares Change (YoY) | 4.87% | -2.53% | 18.68% | 65.04% | 342.39% |
EPS (Basic) | -0.06 | -0.06 | 0.04 | 0.09 | -2.93 |
EPS (Diluted) | -0.06 | -0.06 | 0.04 | 0.09 | -2.93 |
EPS Growth | - | - | -53.90% | - | - |
Free Cash Flow | 91.17 | -176.44 | -183.54 | -98.26 | -213.62 |
Free Cash Flow Per Share | 0.09 | -0.19 | -0.19 | -0.12 | -0.43 |
Dividend Per Share | - | 0.022 | 0.026 | - | - |
Dividend Growth | - | -13.24% | - | - | - |
Gross Margin | 44.01% | 47.75% | 46.75% | 43.80% | 52.43% |
Operating Margin | -18.78% | -17.69% | -8.68% | 1.96% | 3.02% |
Profit Margin | -6.29% | -5.88% | 4.27% | 5.44% | -156.28% |
Free Cash Flow Margin | 9.77% | -19.02% | -18.98% | -7.09% | -22.95% |
EBITDA | -128.53 | -117.24 | -33.66 | 75.49 | 63.85 |
EBITDA Margin | -13.77% | -12.64% | -3.48% | 5.44% | 6.86% |
D&A For EBITDA | 46.8 | 46.8 | 50.33 | 48.3 | 35.72 |
EBIT | -175.33 | -164.04 | -83.99 | 27.19 | 28.13 |
EBIT Margin | -18.78% | -17.69% | -8.68% | 1.96% | 3.02% |
Effective Tax Rate | - | - | 15.87% | 7.00% | - |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.